Dafna Capital Management LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $344 Million distributed in 76 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spdr Ser Tr Spdr S&P Biotech E with a value of $34.5M, Stereotaxis, Inc. with a value of $29M, Revolution Medicines, Inc. with a value of $24.9M, Blueprint Medicines Corp with a value of $21.6M, and Merus N.V. with a value of $21M.

Examining the 13F form we can see an increase of $12.6M in the current position value, from $331M to 344M.

Dafna Capital Management LLC is based out at Los Angeles, CA

Below you can find more details about Dafna Capital Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $344 Million
Healthcare: $296 Million
ETFs: $47.4 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 76
  • Current Value $344 Million
  • Prior Value $331 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 3 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 21 stocks
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.